Department of Infectious Diseases
- About us
- Meet the team
- GCEID in partnership with the Department of Infectious Diseases
- 2018 highlights
- View publications
The Barwon Health Department of Infectious Diseases and Infection Prevention is an academic tertiary referral program and incorporates:
- Expert infection prevention/control service across all Barwon Health sites.
- Infectious diseases services including consultations, inpatient care and antimicrobial stewardship to all acute care sites.
- Accredited advanced training in infectious diseases and microbiology.
- Specialised ambulatory and outpatient services for general infectious diseases, Hospital in the Home, HIV management, sexual and reproductive health, viral hepatitis and refugee health service with multidisciplinary models of care and paediatric input.
- Psychiatry and pharmacy specialist liaison services and comprehensive community case management programs (HIV/HARP).
- 24-hour community HIV post exposure prophylaxis service.
- Extensive infectious diseases research programs in clinical, basic sciences, public health and epidemiology.
The Department works closely with Deakin University, with many of our physicians and staff having teaching roles and academic appointments with the university. We also have close links with the Geelong Centre for Emerging Infectious Diseases (GCEID), a collaborative, multidisciplinary research partnership between Deakin University, Barwon Health and the Australian Animal Health Laboratory (AAHL) and links with Alice Springs Hospital (with our registrars rotating to Central Australia for six month placements).
The Department has active research collaborations locally and internationally, as well as running an active infectious diseases clinical trials unit.
Geelong Centre for Emerging Infectious Diseases (GCEID) in partnership with the Department of Infectious Diseases
We are a multidisciplinary research team including basic genomic and pathogen biology scientists, environmental scientists, public health specialists, epidemiologists and expert clinicians.
We are tackling diseases of public health importance including: emerging infections such Mycobacteria ulcerans (Buruli ulcer), zoonotic infections: Coxiella, Rickettsia, Biofilm infections of medical devices - orthopaedic and cardiac, and virulent pathogens like Staphylococcus aureus bloodstream infections, Endocarditis and Clostridium difficle.
Our research team and laboratory is uniquely placed across several campuses with access to patients, population cohorts, clinical samples, bio-banking and clinical trials platforms including Phase 1 through 3 studies.
Our work includes host pathogen relationships, molecular epidemiology, disease transmission and dynamics and future preventative strategies for at risk populations.
For further enquires contact:
Professor Eugene Athan
Email [email protected]
Ph 03 4215 2375
Discipline: Infection and Immunity
- On the research front, two team members recently completed and were been awarded PhDs. Dr Amanda Wade in the area of Hepatitis C therapy and Dr Christine Roder in Clostridium difficile novel therapy.
- A/Prof. Daniel O’Brien has undertaken a busy sabbatical term working in the areas of Buruli ulcer (BU) in Victoria and Drug resistant TB in PNG.
- Our team were Partners and CIs in the recently awarded NHMRC Partnership grant for BU control for $3million. Partners: BH, CSIRO, DoH and the Uni of Melbourne. This project is underway to help identify the potential environmental and behavioural factors causing disease transmission.
Last Modified: Monday, 15 April 2019